Prognostic reclassification and survival outcomes in intermediate- and poor-risk nonseminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Jobanputra, Kunal Naishadh
Prakash, Gagan
Arora, Amandeep
Jadhav, Bhagyashri
Pal, Mahendra
Pawar, Akash
Dey, Sayak
Bakshi, Ganesh
Murthy, Vedang
Maitre, Priyamvada
Menon, Nandini Sharrel
Shah, Minit Jalan
Menon, Santosh
Popat, Palak
Ringe-Katdare, Aparna
Sable, Nilesh
Agrawal, Archi
Noronha, Vanita
Prabhash, Kumar
Joshi, Amit
机构：
[1] Tata Mem Hosp, Mumbai, India
[2] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, India
[3] Tata Mem Hosp, Tata Mem Ctr, Mumbai, India
[4] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors
    Necchi, Andrea
    Pond, Gregory R.
    Nicolai, Nicola
    Giannatempo, Patrizia
    Raggi, Daniele
    Adra, Nabil
    Hanna, Nasser H.
    Salyioni, Roberto
    Einhorn, Lawrence H.
    Albany, Costantine
    CLINICAL GENITOURINARY CANCER, 2017, 15 (02) : 306 - 312
  • [2] Suggested reclassification strategy applied to intermediate and poor risk nonseminomatous germ cell tumors (NSGCT): A two-institution combined analysis
    Necchi, Andrea
    Pond, Gregory Russell
    Nicolai, Nicola
    Adra, Nabil
    Giannatempo, Patrizia
    Raggi, Daniele
    Hanna, Nasser H.
    Salvioni, Roberto
    Einhorn, Lawrence H.
    Albany, Costantine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment
    Pentheroudakis, G
    De Bono, JS
    Kaye, SB
    Simpson, A
    Paul, J
    Brown, I
    Pamenter, B
    Kirk, A
    Vasey, P
    Raby, N
    Kirk, D
    BJU INTERNATIONAL, 2003, 92 (01) : 36 - 42
  • [4] EXTRAGONADAL AND POOR RISK NONSEMINOMATOUS GERM-CELL TUMORS - SURVIVAL AND PROGNOSTIC FEATURES
    TONER, GC
    GELLER, NL
    LIN, SY
    BOSL, GJ
    CANCER, 1991, 67 (08) : 2049 - 2057
  • [5] Prognostic risk factors in low stage testicular nonseminomatous germ cell tumors (NSGCT)
    Heidenreich, A
    Mostofi, KF
    Sesterhenn, IA
    Moul, JW
    Engelmann, UH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 160 - 160
  • [6] The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?
    Necchi, Andrea
    Nicolai, Nicola
    Giannatempo, Patrizia
    Raggi, Daniele
    Miceli, Rosalba
    Mariani, Luigi
    Salvioni, Roberto
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : 1 - 4
  • [7] Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors
    Pectasides, Dimitrios
    Pectasides, Eirini
    Papaxoinis, George
    Xiros, Nikolaos
    Kamposioras, Konstantinos
    Tountas, Nikolaos
    Economopoulos, Theofanis
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (06) : 617 - 623
  • [8] Better outcomes for patients with intermediate-risk and poor-risk metastatic germ-cell tumors
    Caroline Barranco
    Nature Clinical Practice Urology, 2006, 3 (3): : 121 - 122
  • [9] Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors
    Feldman, Darren R.
    Hu, James
    Dorff, Tanya B.
    Lim, Kristina
    Patil, Sujata
    Woo, Kaitlin M.
    Carousso, Maryann
    Hughes, Amanda
    Sheinfeld, Joel
    Bains, Manjit
    Daneshmand, Siamak
    Ketchens, Charlene
    Bajorin, Dean F.
    Bosl, George J.
    Quinn, David I.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (21) : 2478 - +
  • [10] Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour
    Shayegan, Bobby
    Carver, Brett S.
    Stasi, Jason
    Motzer, Robert J.
    Bosl, George J.
    Sheinfeld, Joel
    BJU INTERNATIONAL, 2007, 99 (05) : 993 - 997
12345